For example, exon 12‐containing LHX6 can facilitate cervical cancer cell growth by altering the MAPK signaling pathway27; SMIM30 promotes hepatocellular carcinoma development by MAPK pathway activation28; and BATF2 inhibits gastric cancer cell progression by inhibiting ERK signaling.29 This evidence concerns the gene MAPK1 and hepatocellular carcinoma.